These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 1383493)
1. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function. McKenna KF; Baker GB; Coutts RT; Greenshaw AJ J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493 [TBL] [Abstract][Full Text] [Related]
2. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels. Griebel G; Curet O; Perrault G; Sanger DJ Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388 [TBL] [Abstract][Full Text] [Related]
3. Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic function. McKenna KF; McManus DJ; Baker GB; Coutts RT J Neural Transm Suppl; 1994; 41():115-22. PubMed ID: 7931216 [TBL] [Abstract][Full Text] [Related]
4. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat. Coutts RT; Mozayani A; Danielson TJ; Baker GB J Pharm Sci; 1991 Aug; 80(8):765-7. PubMed ID: 1791538 [TBL] [Abstract][Full Text] [Related]
6. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine. Parent MB; Habib MK; Baker GB Biochem Pharmacol; 2000 May; 59(10):1253-63. PubMed ID: 10736426 [TBL] [Abstract][Full Text] [Related]
7. Recent studies on the MAO inhibitor phenelzine and its possible metabolites. McKenna KF; Baker GB; Coutts RT; Rauw G; Mozayani A; Danielson TJ J Neural Transm Suppl; 1990; 32():113-8. PubMed ID: 1982447 [TBL] [Abstract][Full Text] [Related]
8. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline. Todd KG; Baker GB J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840 [TBL] [Abstract][Full Text] [Related]
9. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Paslawski T; Treit D; Baker GB; George M; Coutts RT Psychopharmacology (Berl); 1996 Sep; 127(1):19-24. PubMed ID: 8880939 [TBL] [Abstract][Full Text] [Related]
10. Effects of acute and chronic phenelzine on regional monoamine metabolism in rats and its potentiation by deuterium substitution. Juorio AV; Greenshaw AJ; Boulton AA Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):240-5. PubMed ID: 2429193 [TBL] [Abstract][Full Text] [Related]
11. Task-dependent effects of the antidepressant/antipanic drug phenelzine on memory. Parent MB; Habib MK; Baker GB Psychopharmacology (Berl); 1999 Mar; 142(3):280-8. PubMed ID: 10208320 [TBL] [Abstract][Full Text] [Related]
12. Effects of low-dose 4-fluorotranylcypromine on rat brain monoamine oxidase and neurotransmitter amines. Sherry RL; Baker GB; Coutts RT Biol Psychiatry; 1990 Sep; 28(6):539-43. PubMed ID: 1699613 [No Abstract] [Full Text] [Related]
13. Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum. Parent MB; Master S; Kashlub S; Baker GB Biochem Pharmacol; 2002 Jan; 63(1):57-64. PubMed ID: 11754874 [TBL] [Abstract][Full Text] [Related]
14. Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice. Bourin M; Hascoët M; Colombel MC; Coutts RT; Baker GB J Psychiatry Neurosci; 2002 May; 27(3):178-85. PubMed ID: 12066447 [TBL] [Abstract][Full Text] [Related]
15. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration. Urichuk LJ; Allison K; Holt A; Greenshaw AJ; Baker GB J Affect Disord; 2000 May; 58(2):135-44. PubMed ID: 10781703 [TBL] [Abstract][Full Text] [Related]
16. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain. Davis JN; Carlsson A J Neurochem; 1973 Oct; 21(4):783-90. PubMed ID: 4148239 [No Abstract] [Full Text] [Related]
17. Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain. Paslawski TM; Sloley BD; Baker GB Prog Brain Res; 1995; 106():181-6. PubMed ID: 8584653 [TBL] [Abstract][Full Text] [Related]
18. Beta-adrenoceptors and antidepressants: possible 2-phenylethylamine mediation of chronic phenelzine effects. McManus DJ; Mousseau DD; Paetsch PR; Wishart TB; Greenshaw AJ Biol Psychiatry; 1991 Dec; 30(11):1122-30. PubMed ID: 1663791 [TBL] [Abstract][Full Text] [Related]
19. Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain. Robinson DS; Campbell IC; Walker M; Statham NJ; Lovenberg W; Murphy DL Neuropharmacology; 1979 Oct; 18(10):771-6. PubMed ID: 42024 [No Abstract] [Full Text] [Related]
20. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin. Todd KG; Baker GB J Pharm Pharm Sci; 2008 May; 11(2):14s-21s. PubMed ID: 19203467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]